EnforcementEU

EU Medical Device Regulation (MDR) 2017/745 Penalties and Fines

Understand enforcement risk and reduce exposure with evidence and controls.

MDR penalties are set by Member States, but common triggers and mitigation patterns are predictable.

Back to main artifact Review sources

Author

Sorena AI

Published

Feb 22, 2026

Updated

Feb 22, 2026

Sections

Structured answer sets in this page tree.

Primary sources

Cited legal and guidance references.

Publication metadata

Sorena AI

Published Feb 22, 2026

Updated Feb 22, 2026

Overview

MDR is enforced through competent authorities, notified bodies (where applicable), and market surveillance tools. While the exact fines and sanctions vary by Member State, most enforcement actions follow predictable patterns: a safety signal, a documentation gap, a misleading claim, or an uncontrolled change that breaks traceability. This page focuses on what you can control: evidence readiness and governance.

Section 1

How MDR penalties work (what's predictable vs what's local)

MDR requires Member States to establish rules on penalties for infringements. That means the *exact* amounts and procedures are local.

What's predictable: the types of non-compliance that trigger interventions (corrective actions, restrictions, withdrawals/recalls, certificate impacts, public communications).

You're exposed when you cannot show a coherent evidence chain (claims to risks to controls to tests to clinical evidence to labeling to PMS signals).
Enforcement escalates when issues are systemic (QMS failures) or repeated (missed reporting timelines, recurring CAPA failures).
For notified body routes, certificate suspension/withdrawal risk is often the largest business impact - bigger than fines.

Recommended next step

Use EU Medical Device Regulation (MDR) 2017/745 Penalties and Fines as a cited research workflow

Research Copilot can take EU Medical Device Regulation (MDR) 2017/745 Penalties and Fines from understanding exposure and enforcement with cited answers to a reusable workflow inside Sorena. Teams working on EU Medical Device Regulation (MDR) 2017/745 can keep owners, evidence, and next steps aligned without copying this guide into separate documents.

Research workflow

Open Research Copilot for EU Medical Device Regulation (MDR) 2017/745 Penalties and Fines

Start from EU Medical Device Regulation (MDR) 2017/745 Penalties and Fines and answer scope, timing, and interpretation questions with cited outputs.

Explore next step

Talk to Sorena

Talk through EU Medical Device Regulation (MDR) 2017/745

Review your current process, evidence gaps, and next steps for EU Medical Device Regulation (MDR) 2017/745 Penalties and Fines.

Explore next step

Section 2

Common enforcement triggers (high-signal risk drivers)

These are the patterns that frequently create regulator and notified body findings. Treat them as preventative controls in your MDR program.

If you want one meta-control: change control plus traceability will prevent many failures.

Misleading or inconsistent claims across marketing, IFU, and UI outputs (scope/classification and evidence mismatch).
Missing or incoherent technical documentation (Annex II/III) and weak GSPR checklist traceability (Annex I).
Clinical evaluation weaknesses: unclear endpoints, weak appraisal methods, unjustified equivalence, or outdated CER after changes.
PMS and vigilance failures: poor complaint handling, missed reporting timelines, no trend/signal detection, weak CAPA effectiveness.
Uncontrolled changes: software updates, supplier changes, materials changes, cybersecurity patches not assessed for clinical/regulatory impact.
UDI/EUDAMED data problems: labels not matching registry data, missing updates, or unclear governance for submissions.

Section 3

Practical controls that reduce exposure (what to implement and keep current)

The goal is not more documents The goal is fast, credible answers when asked: what is the device, what is the claim, what evidence supports it, what are the risks, and what changed?

Use this list as your minimum defensibility pack for audits and incident reviews.

Scope and classification memos (versioned) with explicit change triggers.
Technical file index with artifact links; GSPR checklist with evidence references.
CER + equivalence dossier (if used) + update triggers tied to change control and PMS signals.
PMS plan + PSUR/PMS report workflow + vigilance log + trend/signal and CAPA effectiveness records.
Change control records for design/software/supplier changes, including impact assessments and release gates.
UDI/EUDAMED procedures and data quality checks (label and registry and QMS consistency).

Primary sources